Anahit Hamazaspyan

Anahit Hamazaspyan practices at OhioHealth Doctors Hospital in Columbus, Ohio, part of OhioHealth.

Anahit Hamazaspyan's NPI, 1376171090, was assigned on March 29, 2020. Anahit Hamazaspyan graduated from University of Pikeville, Kentucky College of Osteopathic Med in 2020. Anahit Hamazaspyan holds Ohio license 34.016432.

Anahit Hamazaspyan's primary practice is OhioHealth Doctors Hospital, at 5100 West Broad Street, Columbus, OH 43228 in Franklin County. The practice phone is (614) 544-2136.

Anahit Hamazaspyan's primary practice is OhioHealth Doctors Hospital in Columbus, Ohio, part of OhioHealth. Anahit Hamazaspyan is also affiliated with OhioHealth Grant Medical Center. The medical group on file is OhioHealth Physician Group. Dmand AI also links Anahit Hamazaspyan to 1 more hospital outpatient department, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Anahit Hamazaspyan practices, 3 sites in all. Vendor and product names are available with a free account.

Hospitalist is Anahit Hamazaspyan's primary specialty in the NPI Registry, under taxonomy code 208M00000X. Anahit Hamazaspyan is licensed in Ohio.

CMS data shows 307 Medicare services from Anahit Hamazaspyan across 4 procedure codes in 2024, for 120 Medicare patients. Medicare paid $25,103 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 120 Medicare patients who saw Anahit Hamazaspyan in 2024. The largest group is 75 to 84, with 42 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 28% are also on Medicaid. Their average risk score is 2.43, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Anahit Hamazaspyan's median patient age at 73, with 56% women.

In 2024, Anahit Hamazaspyan wrote 240 Medicare Part D claims for 99 patients. 83% of them were for generic drugs. CMS names the drug for 51 of them, across 4 drugs with 11 or more claims each, at $217 in total drug cost. In 2023, CMS named 83 claims across 7 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 80 out of 100 for Anahit Hamazaspyan for performance year 2024, reported as part of a group. Anahit Hamazaspyan accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Anahit Hamazaspyan graduated from University of Pikeville, Kentucky College of Osteopathic Med in 2020.